ARCL Organics Ltd (ARCL) — shareholding pattern, promoter holding, financials and share price
About ARCL Organics Ltd (ARCL)
ARCL Organics Ltd operates in the Commodity Chemicals industry, within the Chemicals sector. It trades on the NSE as ARCL and on the BSE under scrip code 543993. Its ISIN is INE372M01010.
Incorporated in 1992, ARCL Organics Ltd manufactures and sells chemical-based products Hardeners, and specialized One-Shot Resins [1]
ARCL Organics Limited, originally Allied Chemical Private Limited, manufactures liquid resins, dry resins, and formaldehyde. It has expanded its product range over time and operates a fully automated petrochemical complex.
The company successfully amalgamated Allied Resins and Chemicals Limited, integrating their business operations and resources, further strengthening its market presence.
Listed peers in Commodity Chemicals: Kesar Petroproducts Ltd, ZR2 Bioenergy Ltd, Kanchi Karpooram Ltd, Archit Organosys Ltd, AG Ventures Ltd.
Valuation & Returns
10 Jul 2026At ₹180 a share on 10 Jul 2026, ARCL Organics Ltd (ARCL) was valued at a price-to-earnings ratio of 27.75x against an industry P/E of 45.11x and a price-to-book of 1.86x on a book value of ₹96.81 per share as of Mar 2025. Solomo computes return on equity of 6.7% and return on capital employed of 19.74% from filed results. Earnings ratios use consolidated results for the twelve months Jun 2025 to Mar 2026.
- P/E
- 27.75x
- Industry P/E
- 45.11x
- P/B
- 1.86x
- EPS (TTM)
- ₹6.49
- Book value / share
- ₹96.81
- ROE
- 6.7%
- ROCE
- 19.74%
- ROA
- 3.07%
- Debt / equity
- 0.44x
- Dividend yield
- 0%
- EBITDA margin
- 10.3%
- 52-week range
- ₹150 – ₹434.6
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, ARCL Organics Ltd (ARCL) reported revenue of ₹272 crore, net profit of ₹5 crore and earnings per share of ₹6.49. That compares with revenue of ₹251 crore and net profit of ₹12 crore in Mar 2025. Figures are consolidated, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹65.31 crore and net profit ₹2.79 crore (consolidated).
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue (₹ cr) | 141 | 165 | 191 | 251 | 272 |
| Net profit (₹ cr) | 11 | 12 | 11 | 12 | 5 |
| EPS (₹) | 13.16 | 14.59 | 14.12 | 15.41 | 6.49 |
| Measure | 5Y | 3Y | 1Y |
|---|---|---|---|
| Sales growth | 28.77% | 21.05% | 31.39% |
| Profit growth | 35.51% | 3.88% | 9.12% |
| Stock price CAGR | - | - | -30% |
Ownership Summary
Jun 2026As of Jun 2026, promoters hold 69.22% of ARCL Organics Ltd (ARCL) (unchanged from the previous quarter) and domestic institutional investors (DII) hold 0.75%. Market capitalisation was ₹144 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Sep 2023.
Largest disclosed public shareholders in Jun 2026: Arcl Organics Ltd-Listing-Operated By-Sbicap Trustee 9.96%, Stressed Assets Stabilization Fund 3.12%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Jun 2026 | 69.22% | - | - | 0.75% | 30.78% |
| Mar 2026 | 69.22% | - | - | 0.75% | 30.78% |
| Dec 2025 | 69.22% | - | - | 0.75% | 30.78% |
| Sep 2025 | 69.22% | - | - | 0.75% | 30.78% |
| Jun 2025 | 69.22% | - | - | 0.75% | 30.78% |
| Mar 2025 | 69.22% | - | - | 0.75% | 30.78% |
| Dec 2024 | 69.22% | - | - | 0.75% | 30.78% |
| Sep 2024 | 69.22% | - | - | 0.92% | 30.78% |